The fight against dengue fever is gaining momentum with the development of effective vaccines. A recent analysis by Future Market Insights (FMI) forecasts a bright future for the Dengue Vaccines Market, with a projected value of USD 1603.7 million by 2033. This represents an impressive double-digit Compound Annual Growth Rate (CAGR), reflecting the increasing focus on …
Tag Archives: Dengue Vaccines Market
Dengue Vaccines Market Is Expected to Exceed USD 1.6 Billion by 2033, Establishing at a 12.9% CAGR | FMI Study
The fight against dengue fever is gaining momentum with the development of effective vaccines. A recent analysis by Future Market Insights (FMI) forecasts a bright future for the Dengue Vaccines Market, with a projected value of USD 1.6 billion by 2033. This represents an impressive double-digit Compound Annual Growth Rate (CAGR), reflecting the increasing focus …
Global Dengue Vaccines Industry Set for Explosive Double-Digit Growth, Reaching US$1.6 Billion by 2033 | FMI Study
The fight against dengue fever is gaining momentum, propelled by a burgeoning Global Dengue Vaccines Industry. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to experience a phenomenal double-digit Compound Annual Growth Rate (CAGR) in the coming years. This translates to a projected market …
Global Dengue Vaccines Industry to Surge Past US$ 1.6 Billion by 2033, Fueled by New Technologies and Rising Dengue Fever Rates
Future Market Insights (FMI), a leading market research firm, forecasts a robust future for the Global Dengue Vaccines Industry. Their new analysis projects the market to reach a staggering US$ 1,603.7 million by 2033, driven by a significant double-digit Compound Annual Growth Rate (CAGR). Key pharmaceutical companies, having successfully concluded clinical trials, are gearing up …
Global Dengue Vaccines Industry is poised to soar, surpassing US$ 1.6 Billion by 2033 with a strong double-digit CAGR | FMI Reports
The Global Dengue Vaccines Industry is on the cusp of a significant expansion, driven by a rising need for effective solutions against this debilitating mosquito-borne disease. According to a new report by Future Market Insights (FMI), a leading market research firm, the market is projected to surpass a staggering US$ 1.6 billion by 2033, reflecting …
Global Dengue Vaccines Industry Primed to Reach New Heights, Expected to Surpass US$ 1.6 Billion by 2033 with Robust CAGR | FMI Reports
Future Market Insights (FMI), a leading market research firm, has unveiled a comprehensive analysis forecasting promising prospects for the Global Dengue Vaccines Industry. The study anticipates substantial advancements in the sector, with projections indicating a remarkable growth trajectory surpassing US$ 1603.7 million by the year 2033, driven by a robust double-digit Compound Annual Growth Rate …
Global Dengue Vaccines Industry Envisioned to Exceed US$ 1.6 Billion by 2033 with a double-digit CAGR | FMI Reveals
FMI’s analysis reveals promising prospects for the Global Dengue Vaccines Industry, expecting substantial advancements that could propel it beyond US$ 1603.7 million by 2033. The forecast indicates a robust double-digit CAGR throughout the envisaged period. With key pharmaceutical companies concluding clinical trials, analyst express optimism about potential new product launches, significantly expanding the growth horizon. …
Insights from FMI: Dengue Vaccines Market to Maintain 12.9% CAGR, Reaching US$ 1603.7 Million by 2033
The dengue vaccines market is poised for robust expansion, with a projected total valuation set to reach US$ 474.8 million in 2023. Anticipated demand for dengue vaccines is on the rise, with a projected Compound Annual Growth Rate (CAGR) of 12.9% in sales volume (units). Dengue vaccine development has reached a pivotal stage in its …
Dengue Vaccines Market to Witness Remarkable Expansion, Anticipated to Reach US$ 1603.7 Million by 2033, at a CAGR of 12.9%
According to a Future Market Insights (FMI) report, The Dengue Vaccines Market will expand positively, with a total valuation of US$ 474.8 million expected in 2023. The demand for dengue vaccinations is likely to increase at a CAGR of 12.9% by volume (units). Geographic Overview Latin America is expected to remain the second largest market for dengue …